C12Y 304/17011
Glutamate carboxypeptidase
Official title: Glutamate carboxypeptidase (3.4.17.11)
C12Y304/17011 (Glutamate carboxypeptidase) appears on 7 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 11
- Assignees
- 8
- Inventors
- 28
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 3 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 3 |
| 2024 | 1 | 0 |
| 2025 | 2 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for adoptive cell therapy16 Dec 2025US 12,496,310 B2Memorial Sloan Kettering Cancer Center
- Compositions and methods for adoptive cell therapy for cancer4 Mar 2025US 12,241,097 B2Memorial Sloan Kettering Cancer Center
- Compositions and methods for adoptive cell therapy for cancer31 Dec 2024US 12,178,830 B2Memorial Sloan Kettering Cancer Center
- Bioresponsive particles16 May 2023US 11,648,297 B2Board of Regents, The University of Texas System
- Carboxypeptidases and nucleic acids encoding same15 Aug 2006US 7,091,002 B2Novozymes A/S
- Compositions and methods for adoptive cell therapy for cancer23 Apr 2026US 2026/0109675 A1Memorial Sloan Kettering Cancer Center
- Compositions and methods for adoptive cell therapy for cancer16 Apr 2026US 2026/0103696 A1Memorial Sloan Kettering Cancer Center
- Compositions and methods for adoptive cell therapy22 Jun 2023US 2023/0190797 A1Memorial Sloan Kettering Cancer Center
- Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereof16 Mar 2023US 2023/0085357 A1Xeris Pharmaceuticals, Inc.
- Combination therapy with glucarpidase with methotrexate/rituximab to treat cns lymphoma5 Jan 2023US 2023/0000956 A1
Most cited
By later US patents
- Method of obtaining protein hydrolysates16US 6,036,983 ANovo Nordisk A/S · 2000
- Carboxypeptidases and nucleic acids encoding the same4US 6,187,578 B1Novo Nordisk A/S · 2001
- Compositions and methods for adoptive cell therapy for cancer1US 12,178,830 B2Memorial Sloan Kettering Cancer Center · 2024
- Compositions and methods for adoptive cell therapy for cancer1US 12,241,097 B2Memorial Sloan Kettering Cancer Center · 2025